Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C.
about
KASL clinical practice guidelines: management of hepatitis CFinal Report of Unmet Needs of Interferon-Based Therapy for Chronic Hepatitis C in Korea: Basis for Moving into the Direct-Acting Antiviral Era.No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients.Interleukin-28B (rs12979860) gene variation and treatment outcome after peginterferon plus ribavirin therapy in patients with genotype 1 of hepatitis C virus.Incidence and risk factors of hepatitis C virus infection among human immunodeficiency virus (HIV) patients in a large HIV clinic in South Korea.The impact of inosine triphosphatase variants on hemoglobin level and sustained virologic response of chronic hepatitis C in Korean.Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virological response by pegylated interferon and ribavirin.IFN-λ gene polymorphisms as predictive factors in chronic hepatitis C treatment-naive patients without access to protease inhibitors.Real-life prevalence of resistance-associated variants against non-structural protein 5A inhibitors and efficiency of Daclatasvir + Asunaprevir therapy in Korean patients with genotype 1b hepatitis CIs peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?KASL clinical practice guidelines: management of hepatitis C.
P2860
Q26752471-26A12DA5-3164-4ED3-A827-045EC12B8DDEQ33853205-A865BC93-9042-4D71-857B-BC21765D17D4Q33905607-D5E10452-1FB8-4DFE-B8BC-380178AE199CQ35025269-50E141B3-4A1E-43D5-B6C0-AD46E9A52AB4Q37081478-C9BE0552-B4D8-405C-A01A-EFFA8CE451EBQ37098107-266E7D03-08C5-44F3-A5BF-86A74FA3B413Q38433971-7F61AC94-0A04-4116-827D-0D3B848728FDQ38477511-4DD289D6-39C2-4EEE-8A4B-4432D346CFD9Q41521289-DE910141-E4D7-4B4B-9E82-79892C2C4336Q43199205-6DD7D724-6CD5-41EA-A4DC-ED5D35873669Q51836024-22D61AB2-F4B1-484E-9512-0E4750B82F67
P2860
Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Efficacy of peginterferon and ...... ents with chronic hepatitis C.
@ast
Efficacy of peginterferon and ...... ents with chronic hepatitis C.
@en
type
label
Efficacy of peginterferon and ...... ents with chronic hepatitis C.
@ast
Efficacy of peginterferon and ...... ents with chronic hepatitis C.
@en
prefLabel
Efficacy of peginterferon and ...... ents with chronic hepatitis C.
@ast
Efficacy of peginterferon and ...... ents with chronic hepatitis C.
@en
P2093
P2860
P1476
Efficacy of peginterferon and ...... ients with chronic hepatitis C
@en
P2093
Duck Joo Choi
Jae Won Yang
Jong Woo Kim
Ju Hyun Kim
Oh Sang Kwon
Sang Jin Park
Young Kul Jung
Yun Soo Kim
P2860
P304
P356
10.3350/CMH.2012.18.4.360
P577
2012-12-21T00:00:00Z